Nathanielsz James Andrew 4
4 · Propanc Biopharma, Inc. · Filed Aug 20, 2021
Insider Transaction Report
Form 4
Nathanielsz James Andrew
DirectorCEO/CFO
Transactions
- Award
Common stock, par value $0.001
2021-08-17+5,928,000→ 5,928,004 total(indirect: By Trust) - Award
Common stock, par value $0.001
2021-08-17+2,800,000→ 2,800,000 total(indirect: By Spouse)
Signature
/s/ James Nathanielsz|2021-08-19